Efficacy and safety of radiotherapy combined with chemoimmunotherapy versus chemoimmunotherapy alone as first-line treatment for metachronous oligorecurrent esophageal squamous cell carcinoma

PurposeMetachronous oligorecurrence is usually defined as oligometastatic disease diagnosed more than 6 months after primary tumor diagnosis in the absence of active systemic therapy. This study aimed to assess the safety and efficacy of radiotherapy combined with chemoimmunotherapy (RCIT) versus ch...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Xiaoyan Lv, Yuan Wang, Jingyi Ai, Siyu Chen, Yi Tan, Xinbing Li, Xintong Yan, Jun Wang
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	Frontiers Media S.A. 2026-06-01
Ráidu:	Frontiers in Oncology
Fáttát:	chemoimmunotherapy esophageal squamous cell carcinoma metachronous oligorecurrence oligometastatic disease radiotherapy
Liŋkkat:	https://www.frontiersin.org/articles/10.3389/fonc.2026.1803137/full
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!